Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Travere Therapeutics	ImmunoGen	Prelude Therapeutics	DiaMedica Therapeutics	uniQure
Symbol	NASDAQ:TVTX	NASDAQ:IMGN	NASDAQ:PRLD	OTCMKTS:DMCAF	NASDAQ:QURE
Price Information
Current Price	$20.01	$7.33	$41.61	$0.38	$32.55
52 Week Range	Buy	Buy	Hold	N/A	Buy
MarketRank™
Overall Score	1.3	1.5	1.6	0.4	1.7
Analysis Score	3.5	3.3	3.2	0.0	3.5
Community Score	2.8	2.4	2.5	2.1	2.9
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	1.7	1.7	0.0	1.7
Earnings & Valuation Score	0.0	0.0	0.6	0.0	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Hold	N/A	Buy
Consensus Price Target	$42.67	$10.10	$55.80	N/A	$68.46
% Upside from Price Target	113.23% upside	37.79% upside	34.10% upside	N/A	110.33% upside
Trade Information
Market Cap	$1.21 billion	$1.47 billion	$1.48 billion	$1.34 billion	$1.49 billion
Beta	0.77	1.65	N/A	-0.02	1.19
Average Volume	579,060	2,258,677	222,638	131,151	469,884
Sales & Book Value
Annual Revenue	$175.34 million	$82.27 million	N/A	N/A	$7.28 million
Price / Sales	6.90	17.81	N/A	N/A	205.34
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$5.15 per share	($0.51) per share	N/A	N/A	$7.41 per share
Price / Book	3.89	-14.37	N/A	N/A	4.39
Profitability
Net Income	$-146,430,000.00	$-104,130,000.00	N/A	$-2,220,000.00	$-124,200,000.00
EPS	($3.46)	($0.70)	N/A	N/A	($3.11)
Trailing P/E Ratio	N/A	N/A	0.00	0.00	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-40.24%	-77.65%	N/A	N/A	-2,738.33%
Return on Equity (ROE)	-29.27%	N/A	N/A	N/A	-59.64%
Return on Assets (ROA)	-12.25%	-26.98%	N/A	N/A	-41.47%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.71%	N/A	N/A	N/A	0.16%
Current Ratio	6.60%	2.20%	20.96%	N/A	8.62%
Quick Ratio	6.50%	2.20%	20.96%	N/A	8.62%
Ownership Information
Institutional Ownership Percentage	N/A	72.95%	76.21%	N/A	78.34%
Insider Ownership Percentage	4.63%	3.77%	N/A	N/A	2.79%
Miscellaneous
Employees	N/A	79	68	N/A	332
Shares Outstanding	60.44 million	199.94 million	35.50 million	157.14 million	45.93 million
Next Earnings Date	7/29/2021 (Estimated)	5/10/2021 (Confirmed)	6/15/2021 (Estimated)	N/A	5/12/2021 (Estimated)
Optionable	Optionable	Optionable	Not Optionable	Not Optionable	Optionable

Source	Headline
	How To Experience The Unique Cultures Of African Tribes - TravelAwaits travelawaits.com - May 9 at 10:34 PM
	Brothers had unique view of 2016 World Series champs - Daily Herald dailyherald.com - May 9 at 10:34 PM
	Local business offers a unique way to relieve stress — with goats - WIVB.com - News 4 wivb.com - May 9 at 10:34 PM
	Mother’s Day: Maine mom forms unique bond with gorilla at Boston zoo - KIRO Seattle kiro7.com - May 9 at 10:34 PM
	Two classes graduate in unique PSU ceremony \| Education \| unionleader.com - The Union Leader unionleader.com - May 9 at 10:34 PM
	PTAB Declines To Enter Adverse Judgment Against Pre-Institution Disclaimed Claims - JD Supra jdsupra.com - May 8 at 3:15 PM
	Novel Coronavirus' Unique Infectious Profile Makes COVID-19 Difficult to Treat: Lancet \| The Weather Channel - Articles from The Weather Channel \| weather.com - The Weather Channel weather.com - May 8 at 8:51 AM
	Unique-looking bird is one of many animals born during baby boom at San Antonio Zoo - KSAT San Antonio ksat.com - May 8 at 8:51 AM
	When theatres went dark, stagehands struggled to keep their unique community strong - KUOW News and Information kuow.org - May 8 at 8:51 AM
	Unique New Accommodations on Jamaica's South Coast - TravelPulse travelpulse.com - May 8 at 12:23 AM
	SLC veterans home welcomes unique comfort animal - fox13now.com fox13now.com - May 8 at 12:23 AM
	Columbus Woman Has Unique Journey To Motherhood - WCBI wcbi.com - May 8 at 12:23 AM
	NSF's unique R&D effort aims to solve societal challenges - Federal News Network federalnewsnetwork.com - May 7 at 7:23 PM
	Texas treehouse rentals can be unique vacation experience - KSAT San Antonio ksat.com - May 7 at 2:21 PM
	'Unique and unusual' for middle school shooter to be female, says former deputy chief - KUTV 2News kutv.com - May 7 at 2:21 PM
	A Small Brazilian Town Is Beating Covid-19 Through a Unique Experiment - The Wall Street Journal wsj.com - May 7 at 2:21 PM
	Buy Or Fear uniQure NV Stock: QURE's 48% Decline In A Year Despite Revenues Increasing 415% YoY Over The Last 4 Quarters Looks Like A Buying Opportunity. The stock has gained 68% since the end of 2017 due to favorable Changes In Its Total Revenues - Trefis dashboards.trefis.com - May 7 at 9:21 AM
	Bees thrive where it's hot and dry: A unique biodiversity hotspot located in North America - Science Daily sciencedaily.com - May 7 at 4:18 AM
	Breweries and botanists have partnered for a unique fundraiser in Verona - TribLIVE triblive.com - May 7 at 4:18 AM
	'Unique and unusual' for middle school shooter to be female, says former deputy chief - KJZZ kjzz.com - May 7 at 4:18 AM
	Apple has a 'whitelist' of developers who can access unique App Store features - AppleInsider appleinsider.com - May 6 at 11:18 PM
	Unusual semimetal shows evidence of unique surface conduction states - EurekAlert eurekalert.org - May 6 at 6:17 PM
	Unique Logistics Adds 52 New Cargo Charter Flights from Asia to the United States - PRNewswire prnewswire.com - May 6 at 6:17 PM
	Drive-thru and jazz band. A unique graduation in - Bay News 9 baynews9.com - May 6 at 6:17 PM
	Why Moderna, uniQure And Novavax Are Moving Today - Benzinga benzinga.com - May 6 at 6:17 PM

Date	Company	Brokerage	Action
5/7/2021	Travere Therapeutics	BMO Capital Markets	Lower Price Target
4/12/2021	Travere Therapeutics	Wedbush	Lower Price Target
3/3/2021	Travere Therapeutics	SVB Leerink	Reiterated Rating
2/3/2021	Travere Therapeutics	Canaccord Genuity	Boost Price Target
11/23/2020	Travere Therapeutics	Evercore ISI	Initiated Coverage
2/16/2021	ImmunoGen	HC Wainwright	Boost Price Target
12/7/2020	ImmunoGen	Piper Sandler	Boost Price Target
10/2/2020	ImmunoGen	Guggenheim	Upgrade
9/29/2020	ImmunoGen	JPMorgan Chase & Co.	Initiated Coverage
9/18/2020	ImmunoGen	William Blair	Reiterated Rating
12/10/2019	ImmunoGen	Cowen	Reiterated Rating
3/23/2021	Prelude Therapeutics	Morgan Stanley	Boost Price Target
3/9/2021	Prelude Therapeutics	Barclays	Initiated Coverage
11/20/2020	Prelude Therapeutics	Bank of America	Downgrade
10/20/2020	Prelude Therapeutics	The Goldman Sachs Group	Initiated Coverage
4/1/2021	uniQure	Mizuho	Upgrade
3/8/2021	uniQure	Chardan Capital	Boost Price Target
12/22/2020	uniQure	Royal Bank of Canada	Boost Price Target
12/9/2020	uniQure	Jefferies Financial Group	Boost Price Target
11/20/2020	uniQure	Credit Suisse Group	Boost Price Target
11/11/2020	uniQure	Berenberg Bank	Initiated Coverage
11/4/2020	uniQure	Cantor Fitzgerald	Initiated Coverage
8/24/2020	uniQure	Raymond James	Initiated Coverage
7/31/2020	uniQure	Robert W. Baird	Upgrade
6/25/2020	uniQure	Stifel Nicolaus	Lower Price Target

(Data available from 5/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources